Price Alert

Abbott Laboratories (ABT)

NYSE: ABT · Real-Time Price · USD

131.78

2.50 (1.93%)

At close: Aug 15, 2025, 3:10 PM

Abbott Laboratories Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	6.53B	7.62B	7.56B	6.99B	6.28B	6.9B	6.71B	7.83B	9.16B	9.88B	9.59B	8.94B	7.67B	9.8B	9.3B	8.66B	8.05B
Short-Term Investments	312M	351M	230M	232M	367M	383M	338M	320M	371M	288M	313M	353M	483M	450M	390M	286M	318M
Long-Term Investments	907M	886M	912M	877M	818M	799M	788M	799M	776M	766M	764M	734M	763M	903M	941M	948M	832M
Other Long-Term Assets	16.84B	15.38B	8.01B	7.65B	7.49B	5.97B	6.53B	6.51B	6.43B	4.92B	5.37B	5.36B	5.5B	3.97B	3.92B	3.71B	3.74B
Receivables	7.33B	6.92B	7.05B	6.85B	6.61B	6.57B	6.5B	6.17B	6.02B	6.22B	6.41B	7.2B	7.18B	6.49B	6.41B	6.11B	6.1B
Inventory	6.64B	6.19B	6.81B	6.81B	6.83B	6.57B	6.65B	6.87B	6.67B	6.17B	5.73B	5.9B	5.69B	5.16B	5.26B	5.44B	5.39B
Other Current Assets	2.34B	2.57B	2.15B	2.23B	2.29B	2.26B	2.47B	2.31B	2.15B	2.66B	2.8B	2.57B	2.4B	2.35B	2.13B	2.13B	1.96B
Total Current Assets	23.15B	23.66B	23.8B	23.12B	22.38B	22.67B	22.66B	23.5B	24.38B	25.22B	24.84B	24.96B	23.43B	24.24B	23.49B	22.63B	21.82B
Property-Plant & Equipment	10.93B	11.73B	10.62B	10.23B	10.11B	11.28B	9.55B	9.45B	9.28B	10.28B	8.69B	8.82B	8.91B	10.11B	8.83B	8.82B	8.83B
Goodwill & Intangibles	29.62B	29.75B	31.01B	31.14B	31.68B	32.49B	32.56B	33.09B	32.93B	33.25B	33.13B	34.34B	35.4B	35.97B	36.61B	37.17B	37.56B
Total Long-Term Assets	58.3B	57.76B	50.55B	49.9B	50.09B	50.54B	49.43B	49.85B	49.42B	49.21B	47.96B	49.25B	50.58B	50.96B	50.3B	50.64B	50.97B
Total Assets	81.45B	81.41B	74.36B	73.02B	72.47B	73.21B	72.09B	73.35B	73.79B	74.44B	72.8B	74.2B	74.01B	75.2B	73.8B	73.27B	72.78B
Account Payables	4.21B	4.2B	4.03B	4.13B	4.18B	4.29B	3.96B	4.21B	4.17B	4.61B	4.13B	4.49B	4.76B	4.41B	4.02B	4.02B	4.07B
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	506M	1.75B	2.15B	1.61B	2.01B	1.32B	1.05B	2.28B	2.29B	2.48B	1.12B	5M	4M	999M	951M	954M	955M
Other Current Liabilities	6.63B	5.91B	6.38B	6.03B	6.18B	6.13B	6.23B	6.22B	6.65B	6.5B	6.29B	6.22B	6.4B	5.77B	6.06B	6.15B	6.05B
Total Current Liabilities	13B	14.16B	14.9B	13.76B	14.02B	13.84B	13.04B	14.35B	14.53B	15.49B	13.37B	12.39B	12.65B	13.11B	12.87B	12.61B	12.46B
Long-Term Debt	12.74B	12.63B	12.82B	13.14B	12.58B	13.6B	14.48B	14.56B	14.62B	14.52B	15.3B	16.75B	17.09B	17.3B	17.45B	17.55B	17.49B
Other Long-Term Liabilities	6.64B	4.46B	6.6B	6.56B	6.83B	4.78B	6.88B	7.04B	7.42B	4.74B	8.26B	8.34B	8.64B	5.74B	8.84B	9.08B	9.05B
Total Long-Term Liabilities	19.38B	19.36B	19.43B	19.7B	19.4B	20.55B	21.35B	21.6B	22.03B	22.04B	23.55B	25.09B	25.73B	26.07B	26.29B	26.63B	26.54B
Total Liabilities	32.38B	33.51B	34.33B	33.46B	33.42B	34.39B	34.4B	35.95B	36.56B	37.53B	36.92B	37.49B	38.38B	39.17B	39.16B	39.24B	39B
Total Debt	13.24B	15.28B	14.98B	14.75B	14.59B	15.87B	15.53B	16.85B	16.9B	17.95B	16.41B	16.76B	17.09B	19.25B	18.4B	18.5B	18.44B
Common Stock	25.13B	25.15B	25.02B	24.86B	24.73B	24.87B	24.73B	24.61B	24.49B	24.71B	24.56B	24.43B	24.3B	24.47B	24.29B	24.15B	24.02B
Retained Earnings	47.72B	47.26B	39.06B	38.35B	38.01B	37.55B	36.92B	36.35B	35.87B	35.26B	35.12B	34.49B	33.3B	31.53B	30.38B	29.05B	28.67B
Comprehensive Income	-7.42B	-7.91B	-7.8B	-8.13B	-8.17B	-7.84B	-8.48B	-8.07B	-8.04B	-8.05B	-9.45B	-8.71B	-8.47B	-8.37B	-9.24B	-9.07B	-9.29B
Shareholders Equity	48.81B	47.66B	39.8B	39.32B	38.81B	38.6B	37.48B	37.17B	37.01B	36.69B	35.67B	36.49B	35.4B	35.8B	34.42B	33.8B	33.56B
Total Investments	1.22B	1.24B	1.14B	1.11B	1.19B	1.18B	1.13B	1.12B	1.15B	1.05B	1.08B	1.09B	1.25B	1.35B	1.33B	1.23B	1.15B